Regulations.gov document
Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications…
Notice · FDA-2022-N-0766 · posted Jul 29, 2022
Key facts
| Document ID | FDA-2022-N-0766-0002 |
|---|---|
| Title | Hospira, Inc., et al.; Withdrawal of Approval of 21 Abbreviated New Drug Applications; Correction |
| Document type | Notice |
| Subtype | Correction |
| Agency | FDA |
| Docket | FDA-2022-N-0766 |
| Posted | Jul 29, 2022 |
| Federal Register citation | 87 FR 45778 |
| FR document number | 2022-16281 |
| Comment period opens | Jul 29, 2022 |
| Effective date | Jul 29, 2022 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: